Skip to main content
SpringerLink
Log in

Impact of Treatments for Painful Diabetic Polyneuropathies on Patients

  • Chapter
  • First Online:
Painful Diabetic Polyneuropathy

  • 1307 Accesses

Abstract

Patients with painful diabetic polyneuropathy (PDN) commonly report neuropathic pain symptoms. Partanen and colleagues found that amongst 132 patients newly diagnosed with non-insulin-dependent diabetes mellitus (NIDDM), 7–13 % reported pain and paraesthesia [1]. In the same patient group 10 years post-diagnosis, 20 % reported pain and 33 % reported paraesthesia. In a study involving 2,610 NIDDM patients, Sorensen and colleagues found that painful neuropathy was present in 11.4 % of those who had a vibration perception threshold ≥30 V and in 3.3 % of those who had a vibration perception threshold <30 [2]. A cross-sectional study conducted in the UK reported that 26.4 % of 269 NIDDM patients with PDN experienced some degree of pain, and amongst those classified as having no neuropathy according to the Toronto Clinical Neuropathy Scoring System, 7.4 % reported pain [3].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Partanen J, et al. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Eng J Med. 1995;333(2):89–94.

    Article  CAS  Google Scholar 

  2. Sorensen L, Molyneaux L, Yue DK. Insensate versus painful diabetic neuropathy: the effects of height, gender, ethnicity and glycemic control. Diabetes Res Clin Pract. 2002;57:45–51.

    Article  PubMed  CAS  Google Scholar 

  3. Davies M, et al. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006;29(7):1518–22.

    Article  PubMed  Google Scholar 

  4. Wong MC, Chung WY, Wong KS. Effects of treatments for symptoms of painful diabetic neuropathy: systematic review. Br Med J. 2007;335:87–96.

    Article  CAS  Google Scholar 

  5. Sindrup SH, et al. Tramadol relieves pain and allodynia in polyneuropathy: a randomized double-blind, controlled trial. Pain. 1999;83:85–90.

    Article  PubMed  CAS  Google Scholar 

  6. Sindrup SH, et al. The effect of tramadol in painful polyneuropathy in relation to serum drug and metabolites levels. Clin Pharmacol Ther. 1999;66:636–41.

    PubMed  CAS  Google Scholar 

  7. Freynhagen R, et al. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain. 2005;115:254–63.

    Article  PubMed  CAS  Google Scholar 

  8. Moon DE, et al. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study. Clin Ther. 2010;32(14):2370–85.

    Article  PubMed  CAS  Google Scholar 

  9. Guan Y, et al. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China. Clin Ther. 2011;33(2):159–66.

    Article  PubMed  CAS  Google Scholar 

  10. Ertas M, et al. Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy. Pain. 1998;75:257–9.

    Article  PubMed  CAS  Google Scholar 

  11. Erdemoglu AK, Varlibas A. Effectiveness of oxcarbazepine in symptomatic treatment of painful diabetic neuropathy. Neurol India. 2006;54(2):173–7.

    PubMed  Google Scholar 

  12. Stracke H, et al. Mexiletine in the treatment of diabetic neuropathy. Diabetes Care. 1992;15:1550–5.

    Article  PubMed  CAS  Google Scholar 

  13. Gorson KC, et al. Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial. J Neurol Neurosurg Psychiatry. 1999;66(2):251–2.

    Article  PubMed  CAS  Google Scholar 

  14. Vinik AI, et al. Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies. Pain. 2007;128:169–79.

    Article  PubMed  CAS  Google Scholar 

  15. Kadiroglu AK, et al. The effect of venlafaxine HCL on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus. J Diabetes Complications. 2008;22:241–5.

    Article  PubMed  Google Scholar 

  16. Gilron I, et al. Pregabalin for peripheral neuropathic pain: a multicenter, enriched enrolment randomized withdrawal placebo-controlled trial. Clin J Pain. 2011;27:185–93.

    Article  PubMed  Google Scholar 

  17. Beydoun S, et al. Long-term safety and tolerability of oxcarbazepine in painful diabetic neuropathy. Acta Neurol Scand. 2007;115:284–588.

    Article  PubMed  CAS  Google Scholar 

  18. Raskin J, et al. Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study. Pain Med. 2006;7(5):373–85.

    Article  PubMed  Google Scholar 

  19. Harati Y, et al. Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. J Diabetes Complications. 2000;14(2):65–70.

    Article  PubMed  CAS  Google Scholar 

  20. Felce D, Perry J. Quality of life: its definition and measurement. Res Dev Disabil. 1995;16(1):51–74.

    Article  PubMed  CAS  Google Scholar 

  21. Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract. 2000;47:123–8.

    Article  PubMed  CAS  Google Scholar 

  22. Benbow SJ, Wallymahmed ME, Macfarlane IA. Diabetic peripheral neuropathy and quality of life. Q J Med. 1998;91(11):733–7.

    Article  CAS  Google Scholar 

  23. Max MB, et al. Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain. 1991;45:3–9.

    Article  PubMed  CAS  Google Scholar 

  24. Sindrup SH, et al. The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy. Clin Pharmacol Ther. 1992;52:547–52.

    Article  PubMed  CAS  Google Scholar 

  25. Kvinesdal B, et al. Imipramine treatment of painful diabetic neuropathy. JAMA. 1984;251:1727–30.

    Article  PubMed  CAS  Google Scholar 

  26. Max MB, et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology. 1987;37:589–96.

    Article  PubMed  CAS  Google Scholar 

  27. Goldstein DJ, et al. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain. 2005;116:109–18.

    Article  PubMed  CAS  Google Scholar 

  28. Raskin J, D’Souza DN, Wernicke JF. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med. 2005;6(5):346–56.

    Article  PubMed  Google Scholar 

  29. Rowbotham MC, et al. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study. Pain. 2004;110:697–706.

    Article  PubMed  CAS  Google Scholar 

  30. Cheung H, Kamp D, Harris E. An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res. 1992;13:107–12.

    Article  PubMed  CAS  Google Scholar 

  31. Ambrósio AF, et al. Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024. Neurochem Res. 2002;27(1/2):121–30.

    Article  PubMed  Google Scholar 

  32. Errington AC, et al. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels. Mol Pharmacol. 2007;73(1):157–69.

    Article  PubMed  Google Scholar 

  33. Pan HL, Eisenach JC, Chen SR. Gabapentin suppresses ectopic nerve discharges and reverses allodynia in neuropathic rats. J Pharmacol Exp Ther. 1999;288:1026–30.

    PubMed  CAS  Google Scholar 

  34. Tremont-Lukats IW, Megett C, Backonja MM. Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy. Drugs. 2000;60(5):1029–52.

    Article  PubMed  CAS  Google Scholar 

  35. Rose MA, Kam PCA. Gabapentin: pharmacology and its use in pain management. Anaesthesia. 2002;57(5):451–62.

    Article  PubMed  CAS  Google Scholar 

  36. Field MJ, et al. Identification of the α2-δ-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin. Proc Natl Acad Sci U S A. 2006;103(46):17537–42.

    Article  PubMed  CAS  Google Scholar 

  37. Taylor CP, Angelotti T, Fauman E. Pharmacology and mechanism of action of pregablin: the calcium channel α2-δ (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res. 2007;73(2):137–50.

    Article  PubMed  CAS  Google Scholar 

  38. Lee WS, et al. Peripheral GABAA receptor-mediated effects of sodium valproate on dural plasma protein extravasation to substance P and Trigeminal stimulation. Br J Pharmacol. 1995;116(1):1661–7.

    Article  PubMed  CAS  Google Scholar 

  39. Cutrer FM, Limmroth VL, Moskowitz MA. Possible mechanisms of valproate in migraine prophylaxis. Cephalalgia. 1997;17(2):93–100.

    Article  PubMed  CAS  Google Scholar 

  40. Kochar DK, et al. Sodium valproate in the management of painful neuropathy in type 2 diabetes—a randomized placebo controlled study. Acta Neurol Scand. 2002;106:248–52.

    Article  PubMed  CAS  Google Scholar 

  41. Kochar DK, et al. Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study. Q J Med. 2004;97:33–8.

    Article  CAS  Google Scholar 

  42. Backonja M, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA. 1998;280(21):1831–6.

    Article  PubMed  CAS  Google Scholar 

  43. Eisenberg E, et al. Lamotrigine reduces painful diabetic neuropathy. A randomized, controlled study. Neurology. 2001;57:505–9.

    Article  PubMed  CAS  Google Scholar 

  44. Rull JA, et al. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol®): double blind crossover trial. Diabetologia. 1969;5:215–8.

    Article  PubMed  CAS  Google Scholar 

  45. Lesser H, et al. Pregabalin relieves symptoms of painful diabetic neuropathy. A randomised controlled trial. Neurology. 2004;63:2104–10.

    Article  PubMed  CAS  Google Scholar 

  46. Rosenstock J, et al. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain. 2004;110:628–38.

    Article  PubMed  CAS  Google Scholar 

  47. Richter RW, et al. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomised, placebo-controlled trial. J Pain. 2005;6(4):253–60.

    Article  PubMed  CAS  Google Scholar 

  48. Arezzo JC, et al. Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial. BMC Neurol. 2008;8:33.

    Article  PubMed  Google Scholar 

  49. Satoh J, et al. Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trial. Diabet Med. 2011;28:109–16.

    Article  PubMed  CAS  Google Scholar 

  50. Rauck RL, et al. Lascosamide in painful diabetic peripheral neuropathy. Clin J Pain. 2007;23:150–8.

    Article  PubMed  Google Scholar 

  51. Shaibani A, et al. Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial. J Pain. 2009;10(8):818–28.

    Article  PubMed  CAS  Google Scholar 

  52. Wymer JP, et al. Efficacy and safety of lacosamide in diabetic neuropathy pain. An 18-week double-blind placebo-controlled trial of fixed-dose regimens. Clin J Pain. 2009;25:376–85.

    Article  PubMed  Google Scholar 

  53. Ziegler A, et al. Efficacy and safety of lacosamide in painful diabetic neuropathy. Diabetes Care. 2010;33:839–41.

    Article  PubMed  CAS  Google Scholar 

  54. Dogra S, et al. Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study. Eur J Pain. 2005;9:543–54.

    Article  PubMed  CAS  Google Scholar 

  55. Beydoun A, et al. Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study. Acta Neurol Scand. 2006;113:395–404.

    Article  PubMed  CAS  Google Scholar 

  56. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy. Neurology. 2003;60:927–34.

    Article  PubMed  CAS  Google Scholar 

  57. Watson CPN, et al. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain. 2003;105:71–8.

    Article  PubMed  CAS  Google Scholar 

  58. Driessen B, Reimann W, Giertz H. Effects of the central analgesic tramadol on the uptake and release of noradrenaline and dopamine in vitro. Br J Pharmacol. 1993;108(3):806–11.

    Article  PubMed  CAS  Google Scholar 

  59. Raffa RB, et al. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an “atypical” opioid analgesic. J Pharmacol Exp Ther. 1992;260(1):275–85.

    PubMed  CAS  Google Scholar 

  60. Reimann W, Hennies HH. Inhibition of spinal noradrenaline uptake in rats by the centrally acting analgesic tramadol. Biochem Pharmacol. 1994;47(12):2289–93.

    Article  PubMed  CAS  Google Scholar 

  61. Harati Y, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology. 1998;50:1842–6.

    Article  PubMed  CAS  Google Scholar 

  62. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain. 1999;83:389–400.

    Article  PubMed  CAS  Google Scholar 

  63. Dejgard A, Petersen P, Kastrup J. Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet. 1988;2:9–11.

    Article  Google Scholar 

  64. Oskarsson P, Ljunggren JG, Lins PE. Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. Diabetes Care. 1997;20:1594–7.

    Article  PubMed  CAS  Google Scholar 

  65. Wright JM, Oki JC, Graves III L. Mexiletine in the symptomatic treatment of diabetic peripheral neuropathy. Ann Pharmacother. 1997;31:29–34.

    PubMed  CAS  Google Scholar 

  66. Nelson KA, et al. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology. 1997;48:1212–8.

    Article  PubMed  CAS  Google Scholar 

  67. Selvarajah D, et al. Randomized placebo-controlled double-blind clinical trial of cannabis-based medicinal product (Sativex) in painful diabetic neuropathy. Diabetes Care. 2010;33: 128–30.

    Article  PubMed  Google Scholar 

  68. Yuen KCJ, Baker NR, Rayman G. Treatment of chronic painful diabetic neuropathy with ­isosordibe dinitrate spray. A double-blind placebo-controlled cross-over study. Diabetes Care. 2002;25:1699–703.

    Article  PubMed  CAS  Google Scholar 

  69. Agrawal RP, et al. Glyceryl trinitrate spray in the management of painful diabetic neuropathy: a randomized double blind placebo controlled cross-over study. Diabetes Res Clin Pract. 2007;77:161–7.

    Article  PubMed  CAS  Google Scholar 

  70. Agrawal RP, et al. Management of diabetic neuroapthy by sodium valproate and glyceryl trinitrate spray: a prospective double-blind randomized placebo-controlled study. Diabetes Res Clin Pract. 2009;83:371–8.

    Article  PubMed  CAS  Google Scholar 

  71. Capsaicin study group. Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehicle-controlled study. Arch Intern Med. 1991;151:2225–9.

    Article  Google Scholar 

  72. Otto M, et al. Pain phenomena and possible mechanism in patients with painful polyneuropathy. Pain. 2003;101:187–92.

    Article  PubMed  Google Scholar 

  73. Galer BS, Gianas A, Jensen MP. Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract. 2000;47:123–8.

    Article  PubMed  CAS  Google Scholar 

  74. Kane K, Taub A. A history of local electrical analgesia. Pain. 1975;1:125–38.

    Article  PubMed  CAS  Google Scholar 

  75. Melzack R, Wall PD. The challenge of pain. London: Penguin Books Ltd.; 1996.

    Google Scholar 

  76. Wall PD, Sweet WH. Temporary abolition of pain in man. Science. 1967;155(3758):108.

    Article  PubMed  CAS  Google Scholar 

  77. Jones L, Johnson MI. Transcutaneous electrical nerve stimulation. Contin Educ Anaesth Crit Care Pain. 2009;9(4):130–5.

    Article  Google Scholar 

  78. Hansson P, Lundeberg T. Transcutaneous electrical nerve stimulation, vibration and acupuncture as pain-relieving measures. In: Wall PD, Melzack R, editors. Textbook of pain. London: Churchill Livingstone; 1999.

    Google Scholar 

  79. Jin DM, et al. Effect of transcutaneous electrical nerve stimulation on symptomatic diabetic peripheral neuropathy: a meta-analysis of randomized controlled trials. Diabetes Res Clin Pract. 2010;89:10–5.

    Article  PubMed  Google Scholar 

  80. Gossrau G, et al. Microcurrent transcutaneous electric nerve stimulation in painful diabetic neuropathy: a randomized placebo-controlled study. Pain Med. 2011;12:953–60.

    Article  PubMed  Google Scholar 

  81. Reichstein L, et al. Effective treatment of symptomatic diabetic polyneuropathy by high-frequency external muscle stimulation. Diabetologia. 2005;48:824–8.

    Article  PubMed  CAS  Google Scholar 

  82. Bosi E, et al. Effectiveness of frequency-modulated electromagnetic neural stimulation in the treatment of painful diabetic neuropathy. Diabetologia. 2005;48:817–23.

    Article  PubMed  CAS  Google Scholar 

  83. de Vos CC, et al. Effect and safety of spinal cord stimulation for treatment of chronic pain caused by diabetic neuropathy. J Diabetes Complications. 2009;23:40–5.

    Article  PubMed  Google Scholar 

  84. Abuaisha BB, Costanzi JB, Boulton AMJ. Acupuncture for the treatment of chronic painful peripheral diabetic neuropathy: a long-term study. Diabetes Res Clin Pract. 1998;39:115–21.

    Article  PubMed  CAS  Google Scholar 

  85. Swislocki A, et al. A randomized clinical trial of the effectiveness of photon stimulation on pain, sensation, and quality of life in patients with diabetic peripheral neuropathy. J Pain Symptom Manage. 2010;39(1):88–99.

    Article  PubMed  Google Scholar 

  86. Weintraub MI, et al. Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind placebo-controlled trial. Arch Phys Med Rehabil. 2003;84:736–46.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ho Yin Pain Management Centre, G/F, No 71, Lake Court, Sai Kung, Hong Kong

    Man-chun Wong R.N., Ph.D.

  2. Department of Health and Physical Education, The Hong Kong Institute of Education, 10 Lo Ping Road, Tai Po, New Territories, Hong Kong

    Joanne W. Y. Chung R.N., Ph.D.

Authors
  1. Man-chun Wong R.N., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joanne W. Y. Chung R.N., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Man-chun Wong R.N., Ph.D. .

Editor information

Editors and Affiliations

  1. , Department of Anesthesiology, University of California San Diego, Campus Point Dr 9300, La Jolla, 92037, California, USA

    Erin Lawson

  2. , Department of Neurology, University of Wisconsin, Highland Avenue 1685, Madison, 53705-2281, Wisconsin, USA

    Miroslav "Misha" Backonja

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Wong, Mc., Chung, J.W.Y. (2013). Impact of Treatments for Painful Diabetic Polyneuropathies on Patients. In: Lawson, E., Backonja, M. (eds) Painful Diabetic Polyneuropathy. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6299-6_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6299-6_14

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-6298-9

  • Online ISBN: 978-1-4614-6299-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation